StockData

Mosaic ImmunoEngineering Inc. (CPMV) stock

CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.33+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.41MP/E –Yield –

Mosaic ImmunoEngineering price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Mosaic ImmunoEngineering's price to book ratio was 238.9× on Mar 31, 2020, against 376.9× a year earlier. Over the last 3 years it ranged from 139.3× to 487.6×, with a median of 351.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Mar 31, 2020238.9×−57.7
2019Dec 31, 2019296.6×−55.2
2018Dec 31, 2018351.8×+57.7
2017Dec 29, 2017294.1×+56.2
2016Dec 30, 2016237.9×−87.0
2015Dec 31, 2015324.9×–

More Mosaic ImmunoEngineering figures

See a number that looks wrong?